Breaking News - Candlesense

Global Medical REIT Inc. Announces the Approval of a $50 Million Common Stock Repurchase Program and One-for-Five Reverse Stock Split

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced that its Board of Directors (the “Board”) approved a $50 million common stock repurc...

What historical performance has GMRE shown following similar buyback or reverse split announcements, and can that inform expected market reaction? Are there any regulatory or tax considerations for shareholders related to the reverse split and share repurchase that could affect after‑tax returns? How might the reverse split affect the REIT's dividend yield and the ability to maintain its current distribution rate?

Symbol: GMRE

Buyback

25 days ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Australian Cancer Trial Advances with First Cohort Complete, Amended Protocol, and Promising Preclinical Data Published; Operating Expenses Cut by 32% Conference Call to be Held Today at 4:30 p.m. ...

How does the updated corporate outlook align with management's previous guidance and analyst expectations? What are the potential regulatory hurdles for the trial's amended protocol and how might they impact timelines? Are there any new collaborations or licensing deals tied to the Australian trial that could boost future earnings?

Symbol: AETH

Earnings

25 days ago

Read more prnewswire

Drilling Tools International Corp. Reports 2025 Second Quarter Results

Company maintains full year 2025 outlook HOUSTON, Aug. 13, 2025 /PRNewswire/ -- Drilling Tools International Corp. (NASDAQ: DTI) ("DTI" or the "Company"), a global oilfield services company that de...

What potential risks or upside catalysts could alter the full‑year 2025 outlook that investors should monitor? How might the current macro‑environment, such as oil price volatility, influence DTI’s outlook and valuation? Did the company provide any guidance on capital expenditures or operating cash flow for the remainder of 2025?

Symbol: DTI

Earnings

25 days ago

Read more prnewswire

Dover Fueling Solutions Introduces Bulloch POS to U.S. Fuel and Convenience Market

DOWNERS GROVE, Ill., Aug. 13, 2025 /PRNewswire/ -- Dover Fueling Solutions ("DFS"), a part of Dover (NYSE: DOV) and a leading global provider of advanced customer-focused technologies, services and...

Could this launch influence the valuation multiples for Dover (DOV) relative to its peers? Will the new POS generate recurring software or services revenue, and if so, what is the forecasted recurring revenue contribution? How does the pricing model of the Bulloch POS compare to existing solutions in the market?

Symbol: DOV

Launch

25 days ago

Read more prnewswire

MSC INCOME FUND ANNOUNCES SECOND QUARTER 2025 RESULTS

Second Quarter 2025 Net Investment Income of $0.35 Per Share Net Asset Value of $15.33 Per Share HOUSTON, Aug. 13, 2025 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE: MSIF) ("MSC Income") is pleased ...

What macroeconomic factors (e.g., inflation, Fed policy, credit spreads) could influence the fund’s future net investment income and NAV trajectory? How does MSC Income Fund’s performance relative to its benchmark index and peer group for the quarter? What is the market’s reaction to the earnings release (price movement, volume), and does it indicate investor sentiment toward MSC Income Fund?

Symbol: MSIF

Earnings

25 days ago

Read more prnewswire

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

REYKJAVIK, Iceland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines f...

Are there any risks or headwinds mentioned (e.g., pricing pressure, competition, supply chain) that could impact the stock price moving forward? What is the market's reaction to the earnings release and conference call, and are there any notable shifts in analyst sentiment? How does Alvotech's performance and valuation compare to other biosimilar peers such as Sandoz, Mylan, or Amgen's biosimilar unit?

Symbol: ALVO

Earnings

25 days ago

Read more globenewswire

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

REYKJAVIK, Iceland, August 13, 2025 - Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldw...

How did the market react to the announcement (pre‑market, after‑hours) and what is the implied short‑term price target? Did management comment on any potential risks, such as patent litigation, supply‑chain constraints, or regulatory delays? What impact could the reported results have on the company's valuation multiples (EV/EBITDA, P/E) relative to peers?

Symbol: ALVO

Earnings

25 days ago

Read more globenewswire

FIGX Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 18, 2025

Tiburon, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FIGX Capital Acquisition Corp. (Nasdaq: FIGXU) (the “Company”) announced today that, commencing August 18, 2025, holders of the units sold in the C...

How might the separation influence analyst coverage, institutional interest, and future financing activities for FIGX? What potential tax implications could arise for investors holding the units when they elect to separate the shares and warrants? How does this separation compare to similar actions taken by other SPACs or listed companies, and what were the market reactions in those cases?

Symbol: FIGXU

Corporate

25 days ago

Read more globenewswire

Dillard’s, Inc. to Report Second Quarter and Year-to-Date Results

LITTLE ROCK, Ark., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Dillard’s, Inc. (DDS: NYSE) will announce results for the 13 and 26 weeks ended August 2, 2025 tomorrow before the open of the New York Stock ...

Will the earnings release trigger any changes in options activity, such as increased implied volatility or adjustments to the options chain? What is the impact of the earnings results on the company’s balance sheet, particularly cash flow and debt levels, and how might that influence capital allocation decisions? Are there any macro‑economic factors (e.g., consumer spending trends, inflation, interest rates) reflected in the results that could affect the retailer’s outlook?

Symbol: DDS

Earnings

25 days ago

Read more globenewswire

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that Henry Fernandez, its Lead Independent Director, has stepped down from its Board of Directors, ef...

What is the historical impact of similar board departures on Royalty Pharma's stock performance? Could this development influence the company's ability to execute upcoming financing or partnership initiatives? Are there any pending regulatory or compliance matters that could be affected by the loss of the Lead Independent Director?

Symbol: RPRX

Board

25 days ago

Read more globenewswire